GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shenzhen Kangtai Biological Products Co Ltd (SZSE:300601) » Definitions » Additional Paid-In Capital

Shenzhen Kangtai Biological Products Co (SZSE:300601) Additional Paid-In Capital : ¥0 Mil(As of Mar. 2025)


View and export this data going back to 2017. Start your Free Trial

What is Shenzhen Kangtai Biological Products Co Additional Paid-In Capital?


Shenzhen Kangtai Biological Products Co's quarterly additional paid-in capital increased from Sep. 2024 (¥0 Mil) to Dec. 2024 (¥3,091 Mil) but then stayed the same from Dec. 2024 (¥3,091 Mil) to Mar. 2025 (¥0 Mil).

Shenzhen Kangtai Biological Products Co's annual additional paid-in capital declined from Dec. 2022 (¥3,208 Mil) to Dec. 2023 (¥3,091 Mil) but then increased from Dec. 2023 (¥3,091 Mil) to Dec. 2024 (¥3,091 Mil).


Shenzhen Kangtai Biological Products Co Additional Paid-In Capital Historical Data

The historical data trend for Shenzhen Kangtai Biological Products Co's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shenzhen Kangtai Biological Products Co Additional Paid-In Capital Chart

Shenzhen Kangtai Biological Products Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Additional Paid-In Capital
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3,626.99 3,627.14 3,207.73 3,090.63 3,091.03

Shenzhen Kangtai Biological Products Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Additional Paid-In Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 3,090.71 - 3,091.03 -

Shenzhen Kangtai Biological Products Co Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

Shenzhen Kangtai Biological Products Co Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Shenzhen Kangtai Biological Products Co's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.


Shenzhen Kangtai Biological Products Co Business Description

Traded in Other Exchanges
N/A
Address
No. 6 Kefa Road, Science and Technology Industrial Park, Nanshan District, Shenzhen, CHN, 518057
Shenzhen Kangtai Biological Products Co Ltd is a human vaccine research and development company. The company is engaged in the research and development, production and sales of recombinant hepatitis B vaccine, b -type influenza Haemophilus conjugate vaccine, measles-rubella combined live attenuated vaccine, cell-free baibai broke b Haemophilus influenzae vaccine and other products.
Executives
Liu Jian Kai Directors, executives
Tao Jin Secretary Dong
Zheng Hai Fa Directors, executives
Zhou Hui Executives
Miao Xiang Directors, executives
Wen Fei Dong Director
Du Wei Min Directors, executives
Lv Zhi Yun Supervisors
Gan Jian Hui Executives
Zhu Zheng Yu Executives
Liu Qun Executives
Li Tong Executives
Yuan Li Ping Director
Li Xiang Ming Independent director

Shenzhen Kangtai Biological Products Co Headlines

No Headlines